Physician profile
Andrew M Nunn
NPI 1598990301
$149,445.30
in general payments reported to CMS, 2019-2025
10 companies · $96K in 2025
The $96K reported for 2025 was more than what 99% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $2,672 · 2022: $4,469 · 2023: $6,874 · 2024: $39K · 2025: $96K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $127K · Travel and Lodging: $12K · Food and Beverage: $3,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $126,546.47 |
| Travel and Lodging | $12,459.86 |
| Food and Beverage | $3,163.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $97,082.97 | 2023-2025 | Evarrest, Vistaseal, Surgiflo Hemostatic Matrix |
| Medical Device Business Services, INC. | $50,486.33 | 2020-2025 | Vistaseal, Evarrest, Ethicon |
| Intuitive Surgical, INC. | $534.73 | 2024 | |
| Zimmer Biomet Holdings, INC. | $265.55 | 2020-2025 | Ribfix Blu Advantage, Ribfix Titan, Advantagerib |
| Atricure, INC. | $257.13 | 2022-2024 | |
| Boston Scientific Corporation | $215.20 | 2023-2024 | Spyglass Discover, Axios |
| Davol INC. | $211.80 | 2024 | Phasix Mesh |
| Ethicon INC. | $145.87 | 2024 | |
| Prytime Medical Devices, INC. | $134.43 | 2019 | |
| Avita Medical Americas, LLC | $111.29 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Nunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.